Tian, Hongzhe
Liu, Bo
Liu, Wei
Yang, JiaRong
Pan, Tiejun
Funding for this research was provided by:
Natural Science Foundation of Hubei Province (No.2020CFB215)
Postdoctoral Program of General Hospital of Central Theater Command (No.BSH021)
Article History
Received: 8 April 2025
Accepted: 22 September 2025
First Online: 18 November 2025
Declarations
:
: The authors declare no competing interests.
: This study was approved by the Ethics Committee of Wuhan Myhalic Biotechnology Co., Ltd (Approval Number: HLK-20221011-001). The study is reported in accordance with ARRIVE guidelines and all methods were performed in accordance with the relevant guidelines and regulations.